Trump rolls back Biden executive order to study methods of lowering prescription costs
- President Donald Trump revoked a Biden executive order aimed at lowering prescription drug costs for Medicare and Medicaid recipients.
- The rescission creates uncertainty about future federal actions on prescription drug pricing, although it does not immediately raise costs.
- Democratic Senator Adam Schiff stated that Trump increased prescription drug costs for Americans on Medicare and Medicaid.
- Some affordable drug policies, like the $35 cap on insulin costs, remain unaffected by Trump's executive order.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left10Leaning Right0Center10Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
